Super Alvitra (Vardenafil/Dapoxetine) – Product Overview

Super Alvitra is a prescription medication formulated to address two common male sexual health concerns: erectile dysfunction (ED) and premature ejaculation (PE). Manufactured by Alpha Pharmaceuticals, the product combines the phosphodiesterase‑5 inhibitor vardenafil with the selective serotonin reuptake inhibitor dapoxetine in a single tablet. Each strip contains five film‑coated tablets, and the available pack sizes are 60, 90, or 120 tablets, allowing patients to choose a quantity that fits their treatment plan. The dual‑action formulation is intended for men who experience difficulty achieving or maintaining an erection and who also wish to delay ejaculation, thereby improving overall sexual satisfaction. This overview provides medically accurate information on the product’s composition, therapeutic intent, and practical usage, supporting both consumer education and search‑engine visibility for e‑commerce platforms.

What is Super Alvitra?

Super Alvitra is classified pharmacologically as a combined vardenafil/dapoxetine tablet. Vardenafil belongs to the class of phosphodiesterase type‑5 (PDE‑5) inhibitors, which enhance blood flow to the penile corpus cavernosum during sexual stimulation. Dapoxetine is a short‑acting selective serotonin reuptake inhibitor (SSRI) that modulates the ejaculatory reflex, increasing the time to ejaculation. The fixed‑dose combination delivers 20 mg of vardenafil and 60 mg of dapoxetine per tablet, a dosage that has been studied in clinical trials for the treatment of concurrent ED and PE. The medication is produced under the quality standards of Alpha Pharmaceuticals, a manufacturer that complies with Good Manufacturing Practice (GMP) regulations as verified by the U.S. Food and Drug Administration (FDA) FDA. The product is packaged in strips of five tablets, each tablet individually scored for ease of splitting if a lower dose is required, though splitting should only be done under medical supervision.

Uses and Benefits

The primary indication for Super Alvitra is the simultaneous management of erectile dysfunction and premature ejaculation in adult men aged 18 to 65. Clinical evidence suggests that the combination can improve erectile rigidity, increase the intravaginal ejaculatory latency time (IELT), and enhance overall sexual confidence. Benefits reported in peer‑reviewed studies include a statistically significant increase in IELT compared with placebo, as well as higher scores on the International Index of Erectile Function (IIEF) questionnaire. For patients who have previously used separate medications for ED and PE, a single tablet may improve adherence and reduce the risk of drug interactions. Additionally, the fixed‑dose format eliminates the need to coordinate two separate prescriptions, simplifying the treatment regimen. These clinical advantages are highlighted in patient‑focused resources such as MedlinePlus, which underscores the importance of integrated therapy for men with coexisting sexual dysfunctions MedlinePlus

How It Works

Super Alvitra exerts its therapeutic effects through complementary mechanisms. Vardenafil inhibits the PDE‑5 enzyme in the penile tissue, preventing the breakdown of cyclic guanosine monophosphate (cGMP). Elevated cGMP levels promote relaxation of smooth muscle and increased arterial inflow, resulting in a firm erection when sexual stimulation is present. Dapoxetine, on the other hand, acts centrally by increasing serotonin activity in the spinal ejaculation pathway, which delays the reflex that triggers ejaculation. The combined action addresses both the vascular component of erection and the neurological component of premature ejaculation. Pharmacokinetic data indicate that vardenafil reaches peak plasma concentrations within 30 to 60 minutes, while dapoxetine is rapidly absorbed and reaches peak levels within one hour, allowing the two agents to work synergistically during the sexual act. For a detailed scientific explanation, refer to the National Institutes of Health’s PubMed database, which hosts peer‑reviewed articles on vardenafil and dapoxetine mechanisms PubMed

Dosage Guidelines

Super Alvitra is prescribed as one tablet taken orally with a full glass of water approximately 30 to 60 minutes before anticipated sexual activity. The recommended starting dose is one tablet (20 mg vardenafil/60 mg dapoxetine) per day, and the dose should not be repeated within a 24‑hour period. Patients with hepatic impairment or those taking strong CYP3A4 inhibitors may require a reduced dose, and such adjustments should be made only under the guidance of a qualified healthcare professional. It is important to avoid consuming grapefruit or grapefruit juice, as it can increase vardenafil levels and potentially lead to adverse effects. Alcohol consumption should be limited, as it may diminish the efficacy of the medication and increase the risk of dizziness. For patients who experience mild side effects, a dose reduction to half a tablet may be considered, but this should be done only after consulting a physician. Detailed prescribing information, including contraindications and drug interaction tables, is available on the FDA’s drug label database FDA Drug Labels

Side Effects

Like all prescription medications, Super Alvitra can cause adverse reactions, although most are mild and transient. Common side effects include headache, facial flushing, nasal congestion, dizziness, and mild nausea. Less frequently, users may experience visual disturbances such as blurred vision or a blue‑tinted perception, which typically resolve without medical intervention. Rare but serious adverse events include prolonged erections (priapism) lasting more than four hours, sudden hearing loss, and severe cardiovascular events such as angina or myocardial infarction, particularly in patients with pre‑existing heart disease. If any of these serious symptoms occur, immediate medical attention is required. Patients should also be aware of the potential for serotonin syndrome when Super Alvitra is combined with other serotonergic agents, such as certain antidepressants or migraine medications. For a comprehensive list of side effects, consult the drug’s package insert or reputable medical reference sites such as Drugs.com Drugs.com

Warnings and Precautions

Super Alvitra is contraindicated in individuals with a known hypersensitivity to vardenafil, dapoxetine, or any component of the formulation. The medication should not be used by patients taking nitrates in any form (e.g., nitroglycerin, isosorbide) due to the risk of severe hypotension. Caution is advised for patients with severe hepatic or renal impairment, as well as for those with a history of cardiac arrhythmias, stroke, or uncontrolled hypertension. Men who have undergone recent surgical procedures involving the pelvis or who have anatomical abnormalities of the penis should discuss potential risks with their physician before initiating therapy. Additionally, Super Alvitra is not intended for use in women or individuals under 18 years of age. To ensure safe use, patients should provide a complete medical history, including all prescription and over‑the‑counter medications, to their prescribing clinician. For official safety communications, refer to the FDA’s MedWatch program MedWatch

Frequently Asked Questions

What is the difference between Super Alvitra and taking vardenafil and dapoxetine separately?

Super Alvitra combines 20 mg of vardenafil with 60 mg of dapoxetine in a single tablet, providing a convenient fixed‑dose option that simplifies the treatment schedule and may improve medication adherence. When taken separately, patients must manage two prescriptions, timing, and potential drug interactions, which can increase the complexity of therapy.

Can Super Alvitra be taken with food?

Super Alvitra can be taken with or without food; however, a high‑fat meal may delay the onset of action for vardenafil and reduce its peak concentration, potentially diminishing efficacy. For optimal results, it is advisable to take the tablet on an empty stomach or after a light meal.

How long does the effect of Super Alvitra last?

The therapeutic effects of vardenafil typically persist for four to five hours, while dapoxetine’s action lasts approximately one to two hours. The combined effect provides a window of improved erectile function and delayed ejaculation that aligns with the natural duration of sexual activity.

Is a prescription required to purchase Super Alvitra?

Yes, Super Alvitra is a prescription‑only medication. A licensed healthcare provider must evaluate a patient’s medical history and current health status before prescribing the drug, ensuring that it is appropriate and safe for the individual.

Are there lifestyle changes that can enhance the effectiveness of Super Alvitra?

Adopting a healthy lifestyle can complement pharmacologic therapy. Regular aerobic exercise, weight management, smoking cessation, and limiting excessive alcohol intake have all been associated with improved erectile function and better control over ejaculation. Psychological counseling or sex therapy may also be beneficial for some men.

Related Products

• Tadalafil/Dapoxetine Orally Disintegrating Strips
• Orgie Plus (Tadalafil/Dapoxetine)
• Cenforce D 160 mg
• Extra Super Tadarise (Tadalafil/Dapoxetine)
• Varda Power (Vardenafil/Dapoxetine)
• Varda Super Power (Vardenafil/Dapoxetine)
• Mahagra 50 Mg (Sildenafil Citrate)
• Mahagra 25 Mg (Sildenafil Citrate)
• Mahagra 200 Mg (Sildenafil Citrate)
• Mahagra (Sildenafil Citrate)
• Begma Tablet
• Alvitra (Vardenafil)